177 related articles for article (PubMed ID: 37991139)
1. Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single-Cell Transcriptomics.
Zhang X; Liang B; Huang Y; Meng H; Li Z; Du J; Zhou L; Zhong Y; Wang B; Lin X; Yu G; Chen X; Lu W; Chen ZS; Yang X; Huang Z
Adv Sci (Weinh); 2023 Dec; 10(36):e2303753. PubMed ID: 37991139
[TBL] [Abstract][Full Text] [Related]
2. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
[TBL] [Abstract][Full Text] [Related]
3. Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma.
Xiang C; Zhang M; Shang Z; Chen S; Zhao J; Ding B; Jiang D; Zhu Q; Teng H; Zhu L; Shao J; Zhao R; Ye M; Yu Y; Han Y
Cell Death Dis; 2023 Aug; 14(8):493. PubMed ID: 37532692
[TBL] [Abstract][Full Text] [Related]
4. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
5. Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing.
Xing X; Yang F; Huang Q; Guo H; Li J; Qiu M; Bai F; Wang J
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571124
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
Wu L; Kang P; Tao S; Zhao Z; Chen L; Xiao Y; Tan Q
BMC Med Genomics; 2020 Jan; 13(1):15. PubMed ID: 32005243
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C
Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172
[TBL] [Abstract][Full Text] [Related]
8. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.
Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T
Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966
[TBL] [Abstract][Full Text] [Related]
9. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
10. Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma.
Zhao Y; Shang J; Gao J; Han H; Gao Z; Yan Y; Zheng Q; Ye T; Fu F; Deng C; Ma Z; Zhang Y; Zheng D; Zheng S; Li Y; Cao Z; Shi L; Chen H
Front Immunol; 2022; 13():921761. PubMed ID: 35844495
[TBL] [Abstract][Full Text] [Related]
11. [Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of
Shen L; Lin J; Wang B; Xu H; Zhao K; Zhang L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Sep; 39(9):1107-1112. PubMed ID: 31640952
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
13. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
15. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
Dejima H; Hu X; Chen R; Zhang J; Fujimoto J; Parra ER; Haymaker C; Hubert SM; Duose D; Solis LM; Su D; Fukuoka J; Tabata K; Pham HHN; Mcgranahan N; Zhang B; Ye J; Ying L; Little L; Gumbs C; Chow CW; Estecio MR; Godoy MCB; Antonoff MB; Sepesi B; Pass HI; Behrens C; Zhang J; Vaporciyan AA; Heymach JV; Scheet P; Lee JJ; Wu J; Futreal PA; Reuben A; Kadara H; Wistuba II; Zhang J
Nat Commun; 2021 May; 12(1):2722. PubMed ID: 33976164
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
Bischoff P; Trinks A; Obermayer B; Pett JP; Wiederspahn J; Uhlitz F; Liang X; Lehmann A; Jurmeister P; Elsner A; Dziodzio T; Rückert JC; Neudecker J; Falk C; Beule D; Sers C; Morkel M; Horst D; Blüthgen N; Klauschen F
Oncogene; 2021 Dec; 40(50):6748-6758. PubMed ID: 34663877
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients.
Jia M; Yu S; Cao L; Sun PL; Gao H
Ann Surg Oncol; 2020 Aug; 27(8):3052-3063. PubMed ID: 32048092
[TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structure and decreased CD8
Wang J; Jiang D; Zheng X; Li W; Zhao T; Wang D; Yu H; Sun D; Li Z; Zhang J; Zhang Z; Hou L; Jiang G; Fei K; Zhang F; Yang K; Zhang P
iScience; 2022 Mar; 25(3):103883. PubMed ID: 35243243
[TBL] [Abstract][Full Text] [Related]
19. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.
Naito M; Aokage K; Saruwatari K; Hisakane K; Miyoshi T; Hishida T; Yoshida J; Masato S; Kojima M; Kuwata T; Fujii S; Ochiai A; Sato Y; Tsuboi M; Ishii G
Lung Cancer; 2016 Oct; 100():53-62. PubMed ID: 27597281
[TBL] [Abstract][Full Text] [Related]
20. Detection and treatment of lung adenocarcinoma at pre-/minimally invasive stage: is it lead-time bias?
Ma Z; Wang Z; Li Y; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2717-2722. PubMed ID: 35524781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
